Hartford Investment Management CO Eagle Pharmaceuticals, Inc. Transaction History

Hartford Investment Management CO

  • $2.99 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 29, 2019
SELL
$38.66 - $51.82 $248,197 - $332,684
-6,420 Closed
0 $0
Q3 2018

Nov 08, 2018
SELL
$66.65 - $83.86 $28,526 - $35,892
-428 Reduced 6.25%
6,420 $445,000
Q2 2018

Jul 19, 2018
BUY
$51.25 - $76.62 $350,960 - $524,693
6,848 New
6,848 $518,000

Others Institutions Holding EGRX

# of Institutions
70
Shares Held
8.6M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email